The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin nad tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial / M.Cohen; GF.Gensini; F.Maritz; EP.Gurfinkel; K.Huber; A.Timerman; M.Krzeminska-Pakula; N.Danchin; HD.White; J.Santopinto; F.Bigonzi; C.Hecquet; L.Vittori. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - STAMPA. - 42:(2003), pp. 1348-1356.
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin nad tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial
GENSINI, GIAN FRANCO;
2003
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
